Zymeworks
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.About ZYME
Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).
CEOKenneth Harry Galbraith
CEOKenneth Harry Galbraith
Employees286
Employees286
HeadquartersMiddletown, Delaware
HeadquartersMiddletown, Delaware
Founded2003
Founded2003
Employees286
Employees286
ZYME Key Statistics
Market cap2.03B
Market cap2.03B
Price-Earnings ratio-31.73
Price-Earnings ratio-31.73
Dividend yield—
Dividend yield—
Average volume584.33K
Average volume584.33K
High today$27.55
High today$27.55
Low today$26.51
Low today$26.51
Open price$26.87
Open price$26.87
Volume237.16K
Volume237.16K
52 Week high$28.49
52 Week high$28.49
52 Week low$9.03
52 Week low$9.03
Stock Snapshot
As of today, Zymeworks(ZYME) shares are valued at $26.87. The company's market cap stands at 2.03B, with a P/E ratio of -31.73.
During the trading session on 2025-12-28, Zymeworks(ZYME) shares reached a daily high of $27.55 and a low of $26.51. At a current price of $26.87, the stock is +1.4% higher than the low and still -2.5% under the high.
Trading activity shows a volume of 237.16K, compared to an average daily volume of 584.33K.
Over the past 52 weeks, Zymeworks(ZYME) stock has traded between a high of $28.49 and a low of $9.03.
Over the past 52 weeks, Zymeworks(ZYME) stock has traded between a high of $28.49 and a low of $9.03.
Analyst ratings
100%
of 14 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ZYME. This list is generated using Robinhood data, and it’s not a recommendation.